Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

Apart from the Department of Health and the Chinese Medicine Council, which other government agencies might regulate my pharmaceutical business?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q418 · Category I: Renewals, changes and penalties for non-compliance (Q401-Q450)
Regulation of the medicine industry involves multiple agencies. In addition to the main regulators, the Drug Office, Department of Health and the Chinese Medicine Council of Hong Kong, you may also deal with other bodies. For example, Hong Kong Customs regulates medicine imports and exports to ensure that all medicines in transit have valid licences and documentation. The Consumer Council has no enforcement powers, but it receives and handles consumer complaints about medicine sales and may publicly name and criticise traders for poor business practices. The Hong Kong Police Force may investigate serious criminal offences, such as selling counterfeit medicines. The Labour Department also oversees occupational safety and health in the workplace, particularly in medicine manufacturing and storage environments.

📘 Regulatory basis

The Import and Export Ordinance (Cap. 60), Trade Descriptions Ordinance (Cap. 362) and various other laws may be relevant to the medicines business.

📗 Drew Tang's recommendations

Compliant business operations require a broad perspective. Our compliance services for clients look beyond pharmaceutical regulations to take account of requirements in areas including customs, consumer protection, advertising and labour safety, helping to build a comprehensive compliance framework.

📕 Risk notice

Do not assume that satisfying the Drug Office is all that matters. An investigation or penalty by any regulatory authority may seriously damage your business’s reputation and operations.

Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗